Related Experiment Video
Updated: Dec 25, 2025

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
9.1K
Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer-Reply
Jeanne Tie1,2,3,4, Bert Vogelstein5, Peter Gibbs1,2,4
1Division of Personalised Oncology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
JAMA Oncology
|April 3, 2020
Abstract
No abstract available in PubMed .

